| Effect of almitrine administration on pulmonary arterial pressure in resting and exercising dogs. | |
| | |
MedLine Citation:
|
PMID: 2125354 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
In addition to its well-known ventilatory effect, a small rise in pulmonary arterial pressure or pulmonary vascular resistance is occasionally observed with chronic administration of almitrine. In order to test the hypothesis of enhancement of exercise pulmonary vasoconstriction by almitrine, mongrel dogs were studied at rest and during submaximal exercise before and after 4 weeks of chronic ingestion of almitrine (10 mg/kg). It was shown that resting pulmonary arterial pressure (PAP) remained unchanged by almitrine treatment. However, when exercise was superimposed on almitrine medication, PAP was significantly increased throughout the exercise bout. Thus, the rise in PAP during the 20th min of exercise averaged 8.7 +/- 3.4 mm Hg after almitrine treatment while PAP increased by only 1.3 +/- 1.7 mm Hg before medication. The exaggerated exercise-induced PAP response in conjunction with the enhanced secretion of norepinephrine that we observed during almitrine treatment suggests that catecholamine could be involved in the pulmonary haemodynamic adjustments. Furthermore, mixed-venous PO2 (PvO2) both during rest and exercise declined with the prolongation of almitrine ingestion, suggesting that PvO2 might possibly be implicated in the pulmonary haemodynamic response to almitrine, in the same way as it is involved in the hypoxia-induced pulmonary vasoconstriction. These findings demonstrate that almitrine medication, even at a high dose, does not have any deleterious effect on pulmonary vasculature in resting conditions, but prolonged submaximal exercise should be proscribed in patients on a long-term therapy. |
| | |
Authors:
|
R J Favier; D Desplanches; R Pagliari; B Semporé; M H Mayet; B Simi; J M Péquignot; J Frutoso; R Flandrois |
Related Documents
:
|
20022264 - Exercise improvement and plasma biomarker changes with intravenous treprostinil therapy... 6806224 - Effect of nitroglycerin on dl of normal subjects at rest and during exercise. 15168144 - Respiratory muscle strength but not basfi score relates to diminished chest expansion i... 6426354 - Oxygen saturation during exercise in cystic fibrosis. 2025694 - Suicide among hospital-treated alcoholics in scotland, 1974-83. 7249544 - Effects of rest, exercise and warming on serum creatine kinase levels in primary hypoth... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Respiration physiology Volume: 82 ISSN: 0034-5687 ISO Abbreviation: Respir Physiol Publication Date: 1990 Oct |
Date Detail:
|
Created Date: 1991-02-19 Completed Date: 1991-02-19 Revised Date: 2009-11-11 |
Medline Journal Info:
|
Nlm Unique ID: 0047142 Medline TA: Respir Physiol Country: NETHERLANDS |
Other Details:
|
Languages: eng Pagination: 75-87 Citation Subset: IM; S |
Affiliation:
|
URA 1341, Faculté de Médecine, Lyon, France. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Almitrine
/
pharmacology* Animals Blood Pressure / drug effects*, physiology Carbon Dioxide / blood Dogs Epinephrine / blood Norepinephrine / blood Oxygen / blood Physical Exertion Pulmonary Artery / drug effects, physiology Pulmonary Circulation / drug effects*, physiology Rest |
| Chemical | |
Reg. No./Substance:
|
124-38-9/Carbon Dioxide; 27469-53-0/Almitrine; 51-41-2/Norepinephrine; 51-43-4/Epinephrine; 7782-44-7/Oxygen |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Isolation and characterization of human thyrotropin-releasing hormone (TRH) from an endocrine pancre...
Next Document: Hereditary lysosomal diseases in Mexico. II. Laboratory diagnosis of mucopolysaccharidosis and mucol...